{"issuance_frequency":"","notes_translated":{"fr":"Ce document vise à fournir la direction aux promoteurs de manière à faciliter la conformité avec les exigences en matière d'étiquetage établies aux termes des articles 3, 9 et 10 de la Loi sur aliments et drogues et des dispositions connexes du Règlement sur les aliments et drogues et de même que de la Loi réglementant certaines drogues et autres substances","en":"The purpose of this document is to provide guidance to sponsors to facilitate compliance with the labelling requirements pursuant to sections 3, 9, and 10 of the Food and Drugs Act as well as related provisions of the Food and Drug Regulations and the Controlled Drugs and Substances Act."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"2bd2dfb9-d1a2-4e22-96c3-e5fc61861c8f","metadata_created":"2021-07-07T16:42:13.516855","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-07T16:42:13.516861","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-07","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Document d'orientation","exigences en matière d'étiquetage","étiquetage des médicaments pharmaceutiques","médicaments à usage humain","Loi sur les aliments et drogues"],"en":["Guidance document","labelling requirements","labelling of pharmaceutical drugs","drugs for human use","Food and Drugs Act"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice : Étiquetage des médicaments pharmaceutiques destinés à l'usage des humains","en":"Guidance Document: Labelling of Pharmaceutical Drugs for Human Use"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"2bd2dfb9-d1a2-4e22-96c3-e5fc61861c8f","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"eae1791c-ae7a-41c7-9fe9-aebec3514995","related_relationship":"","name_translated":{"fr":"Ligne directrice : Étiquetage des médicaments pharmaceutiques destinés à l'usage des humains","en":"Guidance Document: Labelling of Pharmaceutical Drugs for Human Use"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document: Labelling of Pharmaceutical Drugs for Human Use","language":["en"],"created":"2021-07-07T16:42:13.629438","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/labelling-pharmaceutical-drugs-human-use-2014-guidance-document.html","last_modified":null,"position":0,"revision_id":"6f455e42-8b8a-40bb-8f8a-a259e4378cd8","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"2bd2dfb9-d1a2-4e22-96c3-e5fc61861c8f","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d7be08ca-ce78-457b-b408-057668f17b1c","related_relationship":"","name_translated":{"fr":"Ligne directrice : Étiquetage des médicaments pharmaceutiques destinés à l'usage des humains","en":"Guidance Document: Labelling of Pharmaceutical Drugs for Human Use"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document: Labelling of Pharmaceutical Drugs for Human Use","language":["fr"],"created":"2021-07-07T16:42:13.629444","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/etiquetage-medicaments-pharmaceutiques-destines-usage-humains.html#a13","last_modified":null,"position":1,"revision_id":"6f455e42-8b8a-40bb-8f8a-a259e4378cd8","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2015-09-15 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"2bd2dfb9-d1a2-4e22-96c3-e5fc61861c8f","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The purpose of this document is to provide guidance to sponsors to facilitate compliance with the labelling requirements pursuant to sections 3, 9, and 10 of the Food and Drugs Act as well as related provisions of the Food and Drug Regulations and the Controlled Drugs and Substances Act.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance Document: Labelling of Pharmaceutical Drugs for Human Use","revision_id":"6f455e42-8b8a-40bb-8f8a-a259e4378cd8"}